drugset / Trial / NCT02197182

LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study

NCT02197182

Phase 0 Terminated 50 enrolled CDA Research Group, Inc.
RandomizedSingle-groupOpen-labelTreatment

Summary

LUXSOL Cream may be useful for the treatment of bacterial Vaginosis. In this study, LUXSOL Cream is compared to a control arm group using metronidazole cream. LUXSOL is administered intravaginally for 10 days, each evening before bedtime to treat bacterial Vaginosis..

Timeline

Start
2014-06
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject LUXSOL Unknown Other
Comparator Metronidazole Small molecule Other

Indications